{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:46:09Z","timestamp":1788324369073,"version":"build-2803163510"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["BARBIE18G0"],"award-info":[{"award-number":["BARBIE18G0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI14167101A1"],"award-info":[{"award-number":["1R01AI14167101A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5R01AI13715503"],"award-info":[{"award-number":["5R01AI13715503"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"West Virginia University (WVU) Vaccine Development Center WVU institutional startup support"},{"DOI":"10.13039\/100005768","name":"West Virginia Space Grant Consortium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005768","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM133369"],"award-info":[{"award-number":["T32 GM133369"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"Division of Science and Research, WV Higher Education Policy Commission"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Whole cell vaccines are complex mixtures of antigens, immunogens, and sometimes adjuvants that can trigger potent and protective immune responses. In some instances, such as whole cell <jats:italic>Bordetella pertussis<\/jats:italic> vaccination, the immune response to vaccination extends beyond the pathogen the vaccine was intended for and contributes to protection against other clinically significant pathogens. In this study, we describe how <jats:italic>B. pertussis<\/jats:italic> whole cell vaccination protects mice against acute pneumonia caused by <jats:italic>Pseudomonas aeruginosa<\/jats:italic>. Using ELISA and western blot, we identified that <jats:italic>B. pertussis<\/jats:italic> whole cell vaccination induces production of antibodies that bind to lab-adapted and clinical strains of <jats:italic>P. aeruginosa<\/jats:italic>, regardless of immunization route or adjuvant used. The cross-reactive antigens were identified using immunoprecipitation, mass spectrometry, and subsequent immunoblotting. We determined that <jats:italic>B. pertussis<\/jats:italic> GroEL and OmpA present in the <jats:italic>B. pertussis<\/jats:italic> whole cell vaccine led to production of antibodies against <jats:italic>P. aeruginosa<\/jats:italic> GroEL and OprF, respectively. Finally, we showed that recombinant <jats:italic>B. pertussis<\/jats:italic> OmpA was sufficient to induce protection against <jats:italic>P. aeruginosa<\/jats:italic> acute murine pneumonia. This study highlights the potential for use of <jats:italic>B. pertussis<\/jats:italic> OmpA as a vaccine antigen for prevention of <jats:italic>P. aeruginosa<\/jats:italic> infection, and the potential of broadly protective antigens for vaccine development.<\/jats:p>","DOI":"10.1038\/s41541-022-00562-1","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T22:03:19Z","timestamp":1668117799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Bordetella pertussis whole cell immunization protects against Pseudomonas aeruginosa infections"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5898-6736","authenticated-orcid":false,"given":"Catherine B.","family":"Blackwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margalida","family":"Mateu-Borr\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1583-2056","authenticated-orcid":false,"given":"Emel","family":"Sen-Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gage M.","family":"Pyles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Jo","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6954-2479","authenticated-orcid":false,"given":"Kelly L.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa B.","family":"Huckaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5736-0005","authenticated-orcid":false,"given":"Jason","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney E.","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5016-8694","authenticated-orcid":false,"given":"Robert K.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3140-402X","authenticated-orcid":false,"given":"F.","family":"Heath Damron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3250-3636","authenticated-orcid":false,"given":"Mariette","family":"Barbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"562_CR1","unstructured":"Center for Disease Control. Antibiotic resistance threats in the United States. Centers Dis. Control Prev. 114, 1\u2013150 (2019)."},{"key":"562_CR2","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1128\/microbe.10.354.1","volume":"10","author":"WHealth Organization","year":"2015","unstructured":"Organization, W. Health. Global action plan on antimicrobial resistance. Microbe Mag. 10, 354\u2013355 (2015).","journal-title":"Microbe Mag."},{"key":"562_CR3","unstructured":"CDC. Antibiotic resistance threats. Cdc 22\u201350 (2013)."},{"key":"562_CR4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/0091-6749(72)90111-X","volume":"49","author":"C Reed","year":"1971","unstructured":"Reed, C. et al. On the mechanism of the adjuvant effect of Bordetella pertussis vaccine. J. Allergy Clin. Immunol. 49, 174\u2013182 (1971).","journal-title":"J. Allergy Clin. Immunol."},{"key":"562_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1099\/0022-1317-49-2-157","volume":"49","author":"AK Berstad","year":"2000","unstructured":"Berstad, A. K. et al. A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers. J. Med. Microbiol. 49, 157\u2013163 (2000).","journal-title":"J. Med. Microbiol."},{"key":"562_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0264-410X(03)00558-9","volume":"22","author":"A Haugan","year":"2003","unstructured":"Haugan, A. et al. Bordetella pertussis can act as adjuvant as well as inhibitor of immune responses to non-replicating nasal vaccines. Vaccine 22, 7\u201314 (2003).","journal-title":"Vaccine"},{"key":"562_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/08820130600616383","volume":"35","author":"T Maruta","year":"2006","unstructured":"Maruta, T., Oshima, M., Deitiker, P. R., Ohtani, M. & Atassi, M. Z. Use of alum and inactive Bordetella pertussis for generation of antibodies against synthetic peptides in mice. Immunol. Invest. 35, 137\u2013148 (2006).","journal-title":"Immunol. Invest."},{"key":"562_CR8","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1097\/INF.0000000000001269","volume":"35","author":"P Aaby","year":"2016","unstructured":"Aaby, P., Ravn, H. & Benn, C. S. The WHO review of the possible nonspecific effects of Diphtheria-Tetanus-Pertussis vaccine. Pediatr. Infect. Dis. J. 35, 1247\u20131257 (2016).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"562_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ebiom.2017.07.012","volume":"22","author":"P Aaby","year":"2017","unstructured":"Aaby, P., Andersen, A., Ravn, H. & Zaman, K. Co-administration of BCG and Diphtheria-tetanus-pertussis (DTP) vaccinations may reduce infant mortality more than the WHO-schedule of BCG first and then DTP. A re-analysis of demographic surveillance data from rural Bangladesh. EBioMedicine 22, 173\u2013180 (2017).","journal-title":"EBioMedicine"},{"key":"562_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1073\/pnas.1012199108","volume":"108","author":"J-M Song","year":"2011","unstructured":"Song, J.-M., Van Rooijen, N., Bozja, J., Compans, R. W. & Kang, S.-M. Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus. Proc. Natl Acad. Sci. USA 108, 757\u2013761 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"562_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.vaccine.2018.12.005","volume":"37","author":"I Vojtek","year":"2019","unstructured":"Vojtek, I., Buchy, P., Doherty, T. M. & Hoet, B. Would immunization be the same without cross-reactivity? Vaccine 37, 539\u2013549 (2019).","journal-title":"Vaccine"},{"key":"562_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.02631","volume":"10","author":"B Agrawal","year":"2019","unstructured":"Agrawal, B. Heterologous immunity: role in natural and vaccine-induced resistance to infections. Front. Immunol. 10, 1\u201311 (2019).","journal-title":"Front. Immunol."},{"key":"562_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1084\/jem.20101352","volume":"208","author":"J Wrammert","year":"2011","unstructured":"Wrammert, J. et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208, 181\u2013193 (2011).","journal-title":"J. Exp. Med."},{"key":"562_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1007056","volume":"14","author":"P Uppuluri","year":"2018","unstructured":"Uppuluri, P. et al. The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection. PLoS Pathog. 14, 1\u201325 (2018).","journal-title":"PLoS Pathog."},{"key":"562_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nature05762","volume":"447","author":"ES Barton","year":"2007","unstructured":"Barton, E. S. et al. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447, 326\u2013329 (2007).","journal-title":"Nature"},{"key":"562_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1126\/science.aaf1098","volume":"352","author":"MG Netea","year":"2016","unstructured":"Netea, M. G. et al. Trained immunity: a program of innate immune memory in health and disease. Science 352, 427 (2016).","journal-title":"Science"},{"key":"562_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375\u2013388 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"562_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","volume":"9","author":"MG Netea","year":"2011","unstructured":"Netea, M. G., Quintin, J. & Van Der Meer, J. W. M. Trained immunity: a memory for innate host defense. Cell Host Microbe 9, 355\u2013361 (2011).","journal-title":"Cell Host Microbe"},{"key":"562_CR19","first-page":"455","volume":"70","author":"BA Blok","year":"2020","unstructured":"Blok, B. A. et al. Interacting, nonspecific, immunological effects of bacille calmette-gu\u00e9rin and tetanus-diphtheriapertussis inactivated polio vaccinations: an explorative, randomized trial. Clin. Infect. Dis. 70, 455\u2013463 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"562_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/imcb.12246","volume":"97","author":"P Zimmermann","year":"2019","unstructured":"Zimmermann, P., Perrett, K. P., van der Klis, F. R. M. & Curtis, N. The immunomodulatory effects of measles-mumps-rubella vaccination on persistence of heterologous vaccine responses. Immunol. Cell Biol. 97, 577\u2013585 (2019).","journal-title":"Immunol. Cell Biol."},{"key":"562_CR21","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2217\/fmb-2018-0026","volume":"13","author":"E Butkeviciute","year":"2018","unstructured":"Butkeviciute, E., Jones, C. E. & Smith, S. G. Heterologous effects of infant BCG vaccination: potential mechanisms of immunity. Future Microbiol 13, 1193\u20131208 (2018).","journal-title":"Future Microbiol"},{"key":"562_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.vaccine.2018.11.049","volume":"37","author":"K Bollaerts","year":"2019","unstructured":"Bollaerts, K., Verstraeten, T. & Cohet, C. Observational studies of non-specific effects of Diphtheria-Tetanus-Pertussis vaccines in low-income countries: assessing the potential impact of study characteristics, bias and confounding through meta-regression. Vaccine 37, 34\u201340 (2019).","journal-title":"Vaccine"},{"key":"562_CR23","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/bmj.38261.496366.82","volume":"329","author":"J Vaugelade","year":"2004","unstructured":"Vaugelade, J., Pinchinat, S., Guiella, G., Elguero, E. & Simondon, F. Non-specific effects of vaccination on child survival: Prospective cohort study in Burkina Faso. Br. Med. J. 329, 1309\u20131311 (2004).","journal-title":"Br. Med. J."},{"key":"562_CR24","doi-asserted-by":"publisher","unstructured":"Belcher, T. et al. Live attenuated Bordetella pertussis vaccine candidate BPZE1 transiently protects against lethal pneumococcal disease in mice. Vaccine https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.025 (2021).","DOI":"10.1016\/j.vaccine.2021.01.025"},{"key":"562_CR25","first-page":"1","volume":"355","author":"JPT Higgins","year":"2016","unstructured":"Higgins, J. P. T. et al. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review. BMJ 355, 1\u201313 (2016).","journal-title":"BMJ"},{"key":"562_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.02167-20","volume":"12","author":"J Sivinski","year":"2021","unstructured":"Sivinski, J. et al. Functional differences between E. Coli and eskape pathogen groes\/groel. MBio 12, 1\u201316 (2021).","journal-title":"MBio"},{"key":"562_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/595011","volume":"48","author":"HW Boucher","year":"2009","unstructured":"Boucher, H. W. et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 1\u201312 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"562_CR28","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/533452","volume":"197","author":"LB Rice","year":"2008","unstructured":"Rice, L. B. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE. J. Infect. Dis. 197, 1079\u20131081 (2008).","journal-title":"J. Infect. Dis."},{"key":"562_CR29","doi-asserted-by":"crossref","unstructured":"Blackwood, C. B. et al. Innate and adaptive immune responses against Bordetella pertussis and Pseudomonas aeruginosa in a murine model of mucosal vaccination against respiratory infection. Vaccines 8, 1\u201321 (2020).","DOI":"10.3390\/vaccines8040647"},{"key":"562_CR30","doi-asserted-by":"publisher","unstructured":"Sen-Kilic, E. et al. Defining the mechanistic correlates of protection conferred by whole-cell vaccination against Pseudomonas aeruginosa acute murine pneumonia. Infect. Immun. https:\/\/doi.org\/10.1128\/iai.00451-20 (2020).","DOI":"10.1128\/iai.00451-20"},{"key":"562_CR31","doi-asserted-by":"publisher","unstructured":"Sharma, A., Krause, A. & Worgall, S. Recent developments for Pseudomonas vaccines. Hum. Vacc. https:\/\/doi.org\/10.4161\/hv.7.10.16369 (2011).","DOI":"10.4161\/hv.7.10.16369"},{"key":"562_CR32","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1586\/14760584.2014.890053","volume":"13","author":"GP Priebe","year":"2014","unstructured":"Priebe, G. P. & Goldberg, J. B. Vaccines for Pseudomonas aeruginosa: a long and winding road. Expert Rev. Vaccines 13, 507\u2013519 (2014).","journal-title":"Expert Rev. Vaccines"},{"key":"562_CR33","doi-asserted-by":"publisher","unstructured":"Zhou, Z. et al. The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease. J. Cyst. Fibros. https:\/\/doi.org\/10.1016\/S1569-1993(11)60021-0 (2011).","DOI":"10.1016\/S1569-1993(11)60021-0"},{"key":"562_CR34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1203\/00006450-200103000-00019","volume":"49","author":"P Jensen","year":"2001","unstructured":"Jensen, P., Johansen, H. K., Lanng, S. & H\u00d8iby, N. Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis. Pediatr. Res. 49, 423\u2013428 (2001).","journal-title":"Pediatr. Res."},{"key":"562_CR35","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1128\/CDLI.8.4.832-836.2001","volume":"8","author":"PCY Woo","year":"2001","unstructured":"Woo, P. C. Y., Leung, P. K. L., Wong, S. S. Y., Ho, P. L. & Yuen, K. Y. groEL encodes a highly antigenic protein in Burkholderia pseudomallei. Clin. Diagn. Lab. Immunol. 8, 832\u2013836 (2001).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"562_CR36","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1073\/pnas.95.2.478","volume":"95","author":"ES Bochkareva","year":"1998","unstructured":"Bochkareva, E. S., Solovieva, M. E. & Girshovich, A. S. Targeting of GroEL to SecA on the cytoplasmic membrane of Escherichia coli. Proc. Natl Acad. Sci. USA 95, 478\u2013483 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"562_CR37","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1016\/j.bmcl.2011.08.057","volume":"21","author":"G Charbona","year":"2011","unstructured":"Charbona, G. et al. Localization of GroEL determined by in vivo incorporation of a fluorescent amino acid. Bioorg. Med. Chem. Lett. 21, 6067\u20136070 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"562_CR38","doi-asserted-by":"crossref","unstructured":"Fayet, O., Ziegelhoffer, T. & Georgopoulos, C. The groES and groEL heat shock gene products of Escherichia coli are essential for bacterial growth at all temperatures. J. Bacteriol. 171, 1379\u20131385 (1989).","DOI":"10.1128\/jb.171.3.1379-1385.1989"},{"key":"562_CR39","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1086\/318075","volume":"183","author":"JL Burns","year":"2001","unstructured":"Burns, J. L. et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J. Infect. Dis. 183, 444\u2013452 (2001).","journal-title":"J. Infect. Dis."},{"key":"562_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nsmb.1394","volume":"15","author":"Z Lin","year":"2003","unstructured":"Lin, Z., Madan, D. & Rye, H. S. GroEL stimulates protein folding through forced unfolding Zong. Nat. Struct. Mol. Biol. 15, 303\u2013311 (2003).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"562_CR41","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1128\/iai.59.9.3219-3226.1991","volume":"59","author":"A Sipos","year":"1991","unstructured":"Sipos, A., Klocke, M. & Frosch, M. Cloning and sequencing of the genes coding for the 10- and 60-kDa heat shock proteins from Pseudomonas aeruginosa and mapping of a species-specific epitope. Infect. Immun. 59, 3219\u20133226 (1991).","journal-title":"Infect. Immun."},{"key":"562_CR42","unstructured":"Pan\u00e9-Farr\u00e9, J., Quin, M. B., Lewis, R. J. & Marles-Wright, J. Macromolecular Protein Complexes. Sub-Cellular Biochemistry Vol. 83 (2017)."},{"key":"562_CR43","doi-asserted-by":"crossref","unstructured":"Woo, P. C. Y., Leung, P. K. L. & Wong, S. S. Y. groEL encodes a highly antigenic protein in Burkholderia pseudomallei. 8, 832\u2013836 (2001).","DOI":"10.1128\/CDLI.8.4.832-836.2001"},{"key":"562_CR44","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3389\/fimmu.2019.01364","volume":"10","author":"RHM Raeven","year":"2019","unstructured":"Raeven, R. H. M. et al. Antibody specificity following a recent Bordetella pertussis infection in adolescence is correlated with the pertussis vaccine received in childhood. Front. Immunol. 10, 1364 (2019).","journal-title":"Front. Immunol."},{"key":"562_CR45","unstructured":"Chitradevi, S. et al. Recombinant heat shock protein 60 (GroEL) of S. Typhi as an effective adjuvant in modulating the immunogenicity of Invasion plasmid antigen B (IpaB) of Shigella flexneri against lethal Shigella infection in mice. Cell. Mol. Immunol. 4, 7560 (2013)."},{"key":"562_CR46","doi-asserted-by":"crossref","unstructured":"Pechine, S., Hennequin, C., Hoys, S. & Collignon, A. Immunization using GroEL decreases clostridium difficile intestinal colonization. PLoS One. 8, 1\u20139 (2013).","DOI":"10.1371\/journal.pone.0081112"},{"key":"562_CR47","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1073\/pnas.94.6.2192","volume":"94","author":"Z T\u00f6r\u00f6k","year":"1997","unstructured":"T\u00f6r\u00f6k, Z. et al. Evidence for a lipochaperonin: association of active protein-folding GroESL oligomers with lipids can stabilize membranes under heat shock conditions. Proc. Natl Acad. Sci. USA 94, 2192\u20132197 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"562_CR48","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/hq0302.104512","volume":"22","author":"T Huittinen","year":"2002","unstructured":"Huittinen, T. et al. Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary risk. Arterioscler. Thromb. Vasc. Biol. 22, 431\u2013437 (2002).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"562_CR49","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.vetmic.2012.08.019","volume":"163","author":"AW Confer","year":"2013","unstructured":"Confer, A. W. & Ayalew, S. The OmpA family of proteins: roles in bacterial pathogenesis and immunity. Vet. Microbiol. 163, 207\u2013222 (2013).","journal-title":"Vet. Microbiol."},{"key":"562_CR50","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1128\/IAI.00850-10","volume":"79","author":"L Fito-Boncompte","year":"2011","unstructured":"Fito-Boncompte, L. et al. Full virulence of Pseudomonas aeruginosa requires OprF. Infect. Immun. 79, 1176\u20131186 (2011).","journal-title":"Infect. Immun."},{"key":"562_CR51","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/prot.22165","volume":"74","author":"TP Straatsma","year":"2009","unstructured":"Straatsma, T. P. & Soares, T. A. Characterization of the outer membrane protein OprF of Pseudomonas aeruginosa in a lipopolysaccharide membrane by computer simulation. Proteins 74, 475\u2013488 (2009).","journal-title":"Proteins"},{"key":"562_CR52","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jsps.2019.11.021","volume":"28","author":"SI Bukhari","year":"2019","unstructured":"Bukhari, S. I. & Aleanizy, F. S. Association of OprF mutant and disturbance of biofilm and pyocyanin virulence in Pseudomonas aeruginosa. Saudi Pharm. J. 28, 196\u2013200 (2019).","journal-title":"Saudi Pharm. J."},{"key":"562_CR53","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1128\/JB.180.14.3556-3562.1998","volume":"180","author":"EG Rawling","year":"1998","unstructured":"Rawling, E. G., Brinkman, F. S. L. & Hancock, R. E. W. Roles of the carboxy-terminal half of Pseudomonas aeruginosa major outer membrane protein OprF in cell shape, growth in low-osmolarity medium, and peptidoglycan association. J. Bacteriol. 180, 3556\u20133562 (1998).","journal-title":"J. Bacteriol."},{"key":"562_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JB.00050-19","volume":"201","author":"EK Cassin","year":"2019","unstructured":"Cassin, E. K. & Tseng, B. S. Pushing beyond the envelope: the potential roles of OprF in Pseudomonas aeruginosa biofilm formation and pathogenicity. J. Bacteriol. 201, 1\u201312 (2019).","journal-title":"J. Bacteriol."},{"key":"562_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2015.00630","volume":"6","author":"E Bouffartigues","year":"2015","unstructured":"Bouffartigues, E. et al. The absence of the Pseudomonas aeruginosa OprF protein leads to increased biofilm formation through variation in c-di-GMP level. Front. Microbiol. 6, 1\u201313 (2015).","journal-title":"Front. Microbiol."},{"key":"562_CR56","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1006\/mpat.2002.0514","volume":"33","author":"AO Azghani","year":"2002","unstructured":"Azghani, A. O., Idell, S., Bains, M. & Hancock, R. E. Pseudomonas aeruginosa outer membrane protein F is an adhesin in bacterial binding to lung epithelial cells in culture. Micro. Pathog. 33, 109\u2013114 (2002).","journal-title":"Micro. Pathog."},{"key":"562_CR57","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/femsre\/fux020","volume":"41","author":"S Chevalier","year":"2017","unstructured":"Chevalier, S. et al. Structure, function and regulation of Pseudomonas aeruginosa porins. FEMS Microbiol. Rev. 41, 698\u2013722 (2017).","journal-title":"FEMS Microbiol. Rev."},{"key":"562_CR58","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4161\/hv.23226","volume":"9","author":"R Moore","year":"2013","unstructured":"Moore, R. et al. Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infection. Hum. Vaccin. Immunother. 9, 506\u2013514 (2013).","journal-title":"Hum. Vaccin. Immunother."},{"key":"562_CR59","doi-asserted-by":"publisher","unstructured":"Baumann, U., Mansouri, E. & Von Specht, B. U. Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections. Vaccine https:\/\/doi.org\/10.1016\/j.vaccine.2003.11.029 (2004).","DOI":"10.1016\/j.vaccine.2003.11.029"},{"key":"562_CR60","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4161\/hv.26565","volume":"10","author":"K Westritschnig","year":"2014","unstructured":"Westritschnig, K. et al. A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF\/I vaccine (IC43) in healthy volunteers. Hum. Vaccin. Immunother. 10, 170\u2013183 (2014).","journal-title":"Hum. Vaccin. Immunother."},{"key":"562_CR61","doi-asserted-by":"crossref","unstructured":"Peluso, L. et al. Protection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization. BMC Microbiol. 10, 1\u201311 (2010).","DOI":"10.1186\/1471-2180-10-9"},{"key":"562_CR62","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/0264-410X(95)00166-X","volume":"13","author":"EE Hughes","year":"1995","unstructured":"Hughes, E. E. & Gilleland, H. E. Ability of synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa to afford protection against P. aeruginosa infection in a murine acute pneumonia model. Vaccine 13, 1750\u20131753 (1995).","journal-title":"Vaccine"},{"key":"562_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-6968.2007.00778.x","volume":"273","author":"SGJ Smith","year":"2007","unstructured":"Smith, S. G. J., Mahon, V., Lambert, M. A. & Fagan, R. P. A molecular Swiss army knife: OmpA structure, function and expression. FEMS Microbiol. Lett. 273, 1\u201311 (2007).","journal-title":"FEMS Microbiol. Lett."},{"key":"562_CR64","doi-asserted-by":"publisher","unstructured":"Yang, F. et al. PA0833 Is an OmpA C-Like protein that confers protection against Pseudomonas aeruginosa infection. Front. Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2018.01062 (2018).","DOI":"10.3389\/fmicb.2018.01062"},{"key":"562_CR65","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1099\/mic.0.025833-0","volume":"155","author":"FH Damron","year":"2009","unstructured":"Damron, F. H., Napper, J., Teter, M. A. & Yu, H. D. Lipotoxin F of Pseudomonas aeruginosa is an AlgU-dependent and alginate-independent outer membrane protein involved in resistance to oxidative stress and adhesion to A549 human lung epithelia. Microbiology 155, 1028\u20131038 (2009).","journal-title":"Microbiology"},{"key":"562_CR66","doi-asserted-by":"publisher","first-page":"7105","DOI":"10.1128\/JVI.02542-09","volume":"84","author":"R Li","year":"2010","unstructured":"Li, R. et al. Attenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening the cytokine storm. J. Virol. 84, 7105\u20137113 (2010).","journal-title":"J. Virol."},{"key":"562_CR67","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1046\/j.1365-2958.1996.381426.x","volume":"21","author":"HA Barton","year":"1996","unstructured":"Barton, H. A., Johnson, Z., Cox, C. D., Vasil, A. I. & Vasil, M. L. Ferric uptake regulator mutants of Pseudomonas aeruginosa with distinct alterations in the iron-dependent repression of exotoxin A and siderophores in aerobic and microaerobic environments. Mol. Microbiol. 21, 1001\u20131017 (1996).","journal-title":"Mol. Microbiol."},{"key":"562_CR68","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1128\/JB.01479-12","volume":"194","author":"K Held","year":"2012","unstructured":"Held, K., Ramage, E., Jacobs, M., Gallagher, L. & Manoil, C. Sequence-verified two-allele transposon mutant library for Pseudomonas aeruginosa PAO1. J. Bacteriol. 194, 6387\u20136389 (2012).","journal-title":"J. Bacteriol."},{"key":"562_CR69","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1128\/JCM.00349-16","volume":"54","author":"SW Thrane","year":"2016","unstructured":"Thrane, S. W., Taylor, V. L., Lund, O., Lam, J. S. & Jelsbak, L. Application of whole-genome sequencing data for o-specific antigen analysis and in silico serotyping of pseudomonas aeruginosa isolates. J. Clin. Microbiol. 54, 1782\u20131788 (2016).","journal-title":"J. Clin. Microbiol."},{"key":"562_CR70","doi-asserted-by":"crossref","unstructured":"Boehm, D. T. et al. Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis. npj Vaccines 4, (2019).","DOI":"10.1038\/s41541-019-0136-2"},{"key":"562_CR71","doi-asserted-by":"publisher","unstructured":"Sen-Kilic, E. et al. Intranasal peptide-based Fpva-KLH conjugate vaccine protects mice from Pseudomonas aeruginosa acute murine pneumonia. Front. Immunol. 1\u201317, https:\/\/doi.org\/10.3389\/fimmu.2019.02497 (2019).","DOI":"10.3389\/fimmu.2019.02497"},{"key":"562_CR72","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1152\/physiolgenomics.00185.2011","volume":"44","author":"A Livraghi-Butrico","year":"2012","unstructured":"Livraghi-Butrico, A. et al. Genetically determined heterogeneity of lung disease in a mouse model of airway mucus obstruction. Physiol. Genomics 44, 470\u2013484 (2012).","journal-title":"Physiol. Genomics"},{"issue":"Pt 3","key":"562_CR73","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1099\/13500872-145-3-673","volume":"145","author":"S Hern\u00e1ndez-All\u00e9s","year":"1999","unstructured":"Hern\u00e1ndez-All\u00e9s, S. et al. Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology 145(Pt 3), 673\u2013679 (1999).","journal-title":"Microbiology"},{"key":"562_CR74","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1038\/nprot.2006.468","volume":"1","author":"A Shevchenko","year":"2007","unstructured":"Shevchenko, A., Tomas, H., Havli\u0161, J., Olsen, J. V. & Mann, M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat. Protoc. 1, 2856\u20132860 (2007).","journal-title":"Nat. Protoc."},{"key":"562_CR75","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"562_CR76","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The protein data bank. Nucleic Acids Res. 28, 235\u2013242 (2000).","journal-title":"Nucleic Acids Res."},{"key":"562_CR77","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296\u2013W303 (2018).","journal-title":"Nucleic Acids Res."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-022-00562-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-022-00562-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-022-00562-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T19:06:07Z","timestamp":1668279967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-022-00562-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["562"],"URL":"https:\/\/doi.org\/10.1038\/s41541-022-00562-1","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"assertion":[{"value":"22 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.B., F.H.D., and C.B.B. have submitted a provisional patent application (US Patent Application Serial No. 63\/172,259, Cross-protective antigens for vaccination, WVU reference number 2021-035) for the work described in this publication. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}